AgaMatrix - PCDS | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

Resources

AgaMatrix Europe Ltd.

Company profile

The WaveSense JAZZ™ blood glucose meter has been selected as a meter of choice for patients with Type 2 diabetes for the ‘All Wales’ Blood Glucose Meter Formulary.

The WaveSense JAZZ™ test strip has been a popular choice for Health Boards and HCPs for many years, resulting in it being the clear No.1 prescribed test strip in Wales and the 3rd most prescribed test strip in the UK. AgaMatrix have worked hard to secure this position by offering high quality, accurate blood glucose testing combined with second-to-none support.

Find out more about the WaveSense JAZZ™ blood glucose meter and AgaMatrix Clinic Review Service. This free of charge service assists GP practices to optimise blood glucose prescribing and is fully managed from beginning to end by the AgaMatrix pharmacy team under the control of the GP surgery throughout the process. A remote version of the service is now available.

This resource page and the materials included have been organised and funded by AgaMatrix.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.